Marie Christine Semira

Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer.

Angelyn Anton, Sruti Pillai, Marie Christine Semira, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun Azad, Edmond M Kwan, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Olivia Baenziger, Peter Gibbs, Ben Tran

Journal article  |  2022  |  BJUI Compass

INTRODUCTION: Several systemic therapies have demonstrated a survival advantage in metastatic castration resistant prostate cancer..

Molecular classification of hormone-sensitive and castration-resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens

Kobe C Yuen, Ben Tran, Angelyn Anton, Habib Hamidi, Anthony J Costello, Niall M Corcoran, Nathan Lawrentschuk, Natalie Rainey, Marie CG Semira, Peter Gibbs, Sanjeev Mariathasan, Shahneen Sandhu, Edward E Kadel

Journal article  |  2022  |  PROSTATE

BACKGROUND: Despite the rapidly evolving therapeutic landscape, immunotherapy has demonstrated limited activity in prostate cancer..

Real-world incidence of symptomatic skeletal events and bone-modifying agent use in castration-resistant prostate cancer- an Australian multi-centre observational study

Angelyn Anton, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun Azad, Edmond M Kwan, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Marie C Semira, Peter Gibbs, Ben Tran, Carmel Pezaro

Journal article  |  2021  |  EUROPEAN JOURNAL OF CANCER

INTRODUCTION: Bone metastases occur frequently in castration-resistant prostate cancer (CRPC) and may lead to skeletal-related eve..

Resection of colorectal cancer liver metastases in older patients

Seema Kumari, Christine Semira, Margaret Lee, Belinda Lee, Rachel Wong, Louise Nott, Jeremy Shapiro, Peter Gibbs

Journal article  |  2020  |  ANZ JOURNAL OF SURGERY

BACKGROUND: Colorectal cancer remains a common cancer in the western world, with liver resection being the only potentially curati..

Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre study

Edmond M Kwan, Marie C Semira, Alice RT Bergin, Christine Muttiah, Sophie Beck, Angelyn Anton, David Campbell, Shirley Wong, Mark Rosenthal, Peter Gibbs, Ben Tran

Journal article  |  2019  |  INTERNAL MEDICINE JOURNAL

BACKGROUND: The impact of regulatory approvals of new therapies for castration-resistant prostate cancer (CRPC) in Australia is un..

Stage-based variation in the impact of colon cancer surveillance.

Lucy Gately, Christine Semira, Azim Jalali, Ian Faragher, Sumitra Ananda, Suzanne Kosmider, Kathryn M Field, Sheau Wen Lok, Malcolm Steel, Margaret Lee, Rachel Wong, Hui-Li Wong, Peter Gibbs

Conference Proceedings  |  2019  |  JOURNAL OF CLINICAL ONCOLOGY

3609 Background: Multiple meta-analyses have demonstrated that routine surveillance following curative intent colorectal cancer s..

Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?

Christine Semira, Hui-Li Wong, Kathryn Field, Margaret Lee, Belinda Lee, Louise Nott, Jeremy Shapiro, Rachel Wong, Jeanne Tie, Ben Tran, Gary Richardson, Allan Zimet, Lara Lipton, Babak Tamjid, Matthew Burge, Brigette Ma, Julie Johns, Michael Harold, Peter Gibbs

Journal article  |  2019  |  INTERNAL MEDICINE JOURNAL

BACKGROUND: Emerging evidence on the optimal use of chemotherapy and biologics in patients with metastatic colorectal cancer shoul..

Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond

Hui-li Wong, Michael Christie, Lucy Gately, Jeanne Tie, Belinda Lee, Christine Semira, Sheau Wen Lok, Rachel Wong, Peter Gibbs

Journal article  |  2018  |  FUTURE ONCOLOGY

While mismatch repair (MMR) deficiency has been studied extensively, the assessment of MMR status in colorectal and other cancers ..

Previous Bevacizumab and Efficacy of Later Anti-Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer: Results From a Large International Registry

Matthew Burge, Christine Semira, Belinda Lee, Margaret Lee, Suzanne Kosmider, Rachel Wong, Jeremy Shapiro, Brigette Ma, Andrew P Dean, Allan S Zimet, Simone A Steel, Sheau Wen Lok, Javier Torres, Melissa Eastgate, Hui-li Wong, Peter Gibbs

Journal article  |  2018  |  CLINICAL COLORECTAL CANCER

BACKGROUND: The FIRE-3 [5-fluorouracil, folinic acid, and irinotecan (FOLFIRI) plus cetuximab versus FOLFIRI plus bevacizumab in f..

Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival

Margaret M Lee, Andrew MacKinlay, Christine Semira, Christine Schieber, Antonio Jose Jimeno Yepes, Belinda Lee, Rachel Wong, Chathurika KH Hettiarachchige, Natalie Gunn, Jeanne Tie, Hui-Li Wong, Iain Skinner, Ian T Jones, James Keck, Suzanne Kosmider, Ben Tran, Kathryn Field, Peter Gibbs

Journal article  |  2018  |  CLINICAL COLORECTAL CANCER

BACKGROUND: Multiple studies have defined the prognostic and potential predictive significance of the primary tumor side in metast..